BILL vs RAPP · rev $1.46B vs $532.9M cap
Bill Com Holdings Inc (BILL) versus Rapport Therapeutics, Inc. Common Stock (RAPP) — a side-by-side from cached financials, not a winner call.
Bill Com Holdings Inc (BILL) is a software - application company listed on US.
Rapport Therapeutics, Inc. Common Stock (RAPP) is a biotechnology company listed on US.
Latest reported BILL revenue for 2025-06-30 was $1.46B. Net income was $23.8M. Revenue was up 13.4% from 2024-06-30 to 2025-06-30. BILL currently screens at market cap $4.78B.
RAPP does not have a complete income-statement cache yet.
BILL currently screens at market cap $4.78B. RAPP currently screens at market cap $532.9M.
Not investment advice. Open the BILL and RAPP stock pages for the full models.
Not investment advice.